Abstract
Neurodegeneration and brain edema are hallmarks of human malignant brain tumors. Here we show that genetic or pharmacological inhibition of the glutamate transporter xCT (X(c-) system, encoded by SLC7a11) in vivo leads to abrogated neurodegeneration, attenuated perifocal edema and prolonged survival. These results show a crucial role for xCT in glioma-induced neurodegeneration and brain edema, corroborating the concept that edema formation may be in part a consequence of peritumoral cell death.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Transport System y+ / antagonists & inhibitors
-
Amino Acid Transport System y+ / genetics*
-
Amino Acid Transport System y+ / metabolism
-
Brain Edema / pathology*
-
Case-Control Studies
-
Cell Line, Tumor
-
Gene Silencing*
-
Glioma / genetics*
-
Glioma / pathology
-
Humans
-
Neurodegenerative Diseases / pathology*
-
RNA Interference
-
RNA, Small Interfering / metabolism*
Substances
-
Amino Acid Transport System y+
-
RNA, Small Interfering
-
SLC7A11 protein, human